- Latest news▼
-
15:32, April 26 ESCMID: New method of purifying the air with ultraviolet light could protect world from new pandemic
-
08:43, April 26 Enzymes that convert different blood groups into first group are discovered
-
19:41, April 25 Children’s Hospital Los Angeles and International Center of Professional Development Allergy/Immunology Conference
-
17:31, April 25 JAMA: patient grew long, curly eyelashes because of chemotherapy
-
11:08, April 25 Mpox epidemic declared in Republic of the Congo
-
08:31, April 25 OU: quitting smoking 4 times more likely to cure laryngeal cancer
-
01:20, April 25 Paralyzed man in China writes hieroglyphs using neural implants placed in his brain
-
15:11, April 24 Zombie deer disease possibly linked to hunters’ deaths
-
12:27, April 23 Appetite: Scientists found out the secret to the appeal of large portions of fast food
-
10:33, April 23 Scientists test new approach to fighting viruses
-
08:38, April 23 Ketamine may help with postpartum depression
-
22:12, April 22 Unhealthy amount of sugar found in baby food products of a well-known brand
-
19:41, April 22 Air pollution puts health of more than 1.6 billion workers globally at risk
-
17:25, April 22 Scientists found baked goods and lack of sleep to be more dangerous than alcohol
-
16:02, April 22 342 cases of measles recorded in Armenia so far in 2024
All materials
Gene therapy reverses sight loss
A genetic therapy has improved the vision of patients who would otherwise have gone blind.
A clinical study by British scientists has shown that the improvement is long-lasting and so the therapy is suitable to be offered as a treatment.
The researchers will apply for approval to begin trials to treat more common forms of blindness next year.
The therapy involve injecting working copy of the gene into the back of the eyes to help cells regenerate.
The results of the therapy, published in the New England Journal of Medicine, have been tried out on 14 patients in the UK and 18 in the US, Canada and Germany over the past four and a half years.
A team at Oxford University is treating a rare disorder called choroideremia. The disorder affects young men whose light-detecting cells in the backs of their eyes are dying because they have inherited a faulty gene.
Follow NEWS.am Medicine on Facebook and Twitter
- Video
- Event calendar
- Children’s Hospital Los Angeles and International Center of Professional Development Allergy/Immunology Conference
- First Armenian-German Conference entitled “Heart Failure Spring School”
- Allogeneic bone marrow transplant in case of hematological malignancy performed in Armenia for first time
All materials
- Archive
- Most read
month
week
day
- Scientists found baked goods and lack of sleep to be more dangerous than alcohol 1026
- Next pandemic likely to be triggered by flu - scientists 994
- 342 cases of measles recorded in Armenia so far in 2024 951
- Scientists develop new method to safely stimulate immune cells to fight cancer 810
- Cognitively stimulating jobs in midlife could lower dementia risk in old age, study finds 808
- Blood test can determine who is at risk of developing multiple sclerosis - scientists 807
- Air pollution puts health of more than 1.6 billion workers globally at risk 758
- Unhealthy amount of sugar found in baby food products of a well-known brand 755
- Ketamine may help with postpartum depression 754
- Appetite: Scientists found out the secret to the appeal of large portions of fast food 747
- BrainStimulation: electrical brain stimulation alleviates anxiety and depression in the elderly 741
- Scientists test new approach to fighting viruses 730
- Zombie deer disease possibly linked to hunters’ deaths 662
- Mpox epidemic declared in Republic of the Congo 459
- Paralyzed man in China writes hieroglyphs using neural implants placed in his brain 416
- Find us on Facebook
- Poll